Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Roland Buhl, Thomas Wilke, Nils Picker, Olaf Schmidt, Marlene Hechtner, Anke Kondla, Ulf Maywald & Claus F Vogelmeier. (2022) Real-World Treatment of Patients Newly Diagnosed with Chronic Obstructive Pulmonary Disease: A Retrospective German Claims Data Analysis. International Journal of Chronic Obstructive Pulmonary Disease 17, pages 2355-2367.
Read now
Read now
Claus F Vogelmeier, Joanna Diesing, Nils Kossack, Marc Pignot & Felix W Friedrich. (2021) COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2407-2417.
Read now
Read now
Ioanna Tsiligianni, Maria Kampouraki, Despo Ierodiakonou, Ioannis Poulonirakis & Polyvios Papadokostakis. (2019) COPD patients’ characteristics, usual care, and adherence to guidelines: the Greek UNLOCK study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 547-556.
Read now
Read now
Wilhelmine Meeraus, Robert Wood, Rafal Jakubanis, Tim Holbrook, Geoffray Bizouard, Johanna Despres, Camille Correia Da Silva, Gaelle Nachbaur, Sarah H Landis, Yogesh Punekar, Bernard Aguilaniu & Afisi S Ismaila. (2019) COPD treatment pathways in France: a retrospective analysis of electronic medical record data from general practitioners. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 51-63.
Read now
Read now
Roland Buhl, Carl-Peter Criée, Peter Kardos, Claus F Vogelmeier, Konstantinos Kostikas, Nadine S Lossi & Heinrich Worth. (2018) Dual bronchodilation vs triple therapy in the “real-life” COPD DACCORD study. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2557-2568.
Read now
Read now
Takeo Ishii, Masaharu Nishimura, Asako Akimoto, Mark H James & Paul Jones. (2018) Understanding low COPD exacerbation rates in Japan: a review and comparison with other countries. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3459-3471.
Read now
Read now
Peter Kardos, Ingo Mokros, Rüdiger Sauer & Claus F Vogelmeier. (2018) Health status in patients with COPD treated with roflumilast: two large noninterventional real-life studies: DINO and DACOTA. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1455-1468.
Read now
Read now
Eleonore H Koolen, Philip J van der Wees, Gert P Westert, Richard Dekhuijzen, Yvonne F Heijdra & Alex J van ’t Hul. (2018) Evaluation of the COPDnet integrated care model in patients with COPD: the study protocol. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2237-2244.
Read now
Read now
Eleonore H Koolen, Philip J van der Wees, Gert P Westert, Richard Dekhuijzen, Yvonne F Heijdra & Alex J van ’t Hul. (2018) The COPDnet integrated care model. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 2225-2235.
Read now
Read now
Frank Rassouli, Florent Baty, Daiana Stolz, Werner Christian Albrich, Michael Tamm, Sandra Widmer & Martin Hugo Brutsche. (2017) Longitudinal change of COPD assessment test (CAT) in a telehealthcare cohort is associated with exacerbation risk. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 3103-3109.
Read now
Read now
Claus Vogelmeier, Heinrich Worth, Roland Buhl, Carl-Peter Criée, Nadine S Lossi, Claudia Mailänder & Peter Kardos. (2017) “Real-life” inhaled corticosteroid withdrawal in COPD: a subgroup analysis of DACCORD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 487-494.
Read now
Read now
Articles from other publishers (14)
Jia Wen Yeap, Irfhan Ali Hyder Ali, Baharudin Ibrahim & Mei Lan Tan. (2023) Chronic obstructive pulmonary disease and emerging ER stress-related therapeutic targets. Pulmonary Pharmacology & Therapeutics 81, pages 102218.
Crossref
Crossref
Heinrich Worth, Roland Buhl, Carl-Peter Criée, Peter Kardos, Eva Gückel & Claus F. Vogelmeier. (2023) In ‘real world’ patients with COPD, exacerbation history, and not blood eosinophils, is the most reliable predictor of future exacerbations. Respiratory Research 24:1.
Crossref
Crossref
Claus F. Vogelmeier, Heinrich Worth, Roland Buhl, Carl-Peter Criée, Eva Gückel & Peter Kardos. (2022) Impact of switching from triple therapy to dual bronchodilation in COPD: the DACCORD ‘real world’ study. Respiratory Research 23:1.
Crossref
Crossref
Marc Miravitlles, Tomotaka Kawayama & Michael Dreher. (2022) LABA/LAMA as First-Line Therapy for COPD: A Summary of the Evidence and Guideline Recommendations. Journal of Clinical Medicine 11:22, pages 6623.
Crossref
Crossref
Christine R. Jenkins. (2020) Bringing COPD control into the consultation. Respirology 25:11, pages 1110-1111.
Crossref
Crossref
Peter Kardos, Claus F. Vogelmeier, Heinrich Worth, Roland Buhl, Victoria Obermoser & Carl-Peter Criée. (2020) COPD Assessment Test Changes from Baseline Correlate with COPD Exacerbations: A Longitudinal Analysis of the DACCORD Observational Study. Lung 198:3, pages 507-514.
Crossref
Crossref
Timm Greulich. (2019) „Low-dose“-Theophyllin zur Prävention von Exazerbationen bei COPD-Patienten – Eine sinnvolle Therapie?Low-dose theophylline for prevention of exacerbations in COPD patients—A meaningful treatment?. Der Pneumologe 16:2, pages 104-106.
Crossref
Crossref
M. Lommatzsch. (2018) Eosinophile Entzündung der Atemwege: Fokus auf Asthma und COPDEosinophilic inflammation of the airways: focus on asthma and COPD. Der Pneumologe 15:5, pages 344-348.
Crossref
Crossref
S. N. Avdeev, A. S. Belevskiy, Z. R. Aisanov, V. V. Arkhipov, I. V. Leshchenko, S. I. Ovcharenko, A. I. Sinopal’nikov, A. A. Vizel’, A. V. Emel’yanov, A. V. Zhestkov, K. A. Zykov, N. A. Kuzubova, G. G. Prozorova, B. A. Chernyak, N. L. Shaporova & E. I. Shmelev. (2018) Possibilities to prevent acute exacerbation of chronic obstructive pulmonary disease using inhalational therapy. A Report of Expert Panel of Russian Respiratory Society. Russian Pulmonology 28:3, pages 368-380.
Crossref
Crossref
Robert S. Zeiger, Trung N. Tran, Rebecca K. Butler, Michael Schatz, Qiaowu Li, Deepak B. Khatry, Ubaldo Martin, Aniket A. Kawatkar & Wansu Chen. (2018) Relationship of Blood Eosinophil Count to Exacerbations in Chronic Obstructive Pulmonary Disease. The Journal of Allergy and Clinical Immunology: In Practice 6:3, pages 944-954.e5.
Crossref
Crossref
Thomas Hausen. 2018. Pneumologie für die Praxis. Pneumologie für die Praxis
161
168
.
Heinrich Worth, Roland Buhl, Carl-Peter Criée, Peter Kardos, Nadine S. Lossi & Claus F. Vogelmeier. (2017) GOLD 2017 treatment pathways in ‘real life’: An analysis of the DACCORD observational study. Respiratory Medicine 131, pages 77-84.
Crossref
Crossref
Peter Kardos, Claus Vogelmeier, Heinrich Worth, Roland Buhl, Nadine S. Lossi, Claudia Mailänder & Carl-Peter Criée. (2017) A two-year evaluation of the ‘real life’ impact of COPD on patients in Germany: The DACCORD observational study. Respiratory Medicine 124, pages 57-64.
Crossref
Crossref
D. Köhler. (2016) Qualität und Wirtschaftlichkeit in der PneumologieEconomic efficiency and quality in pulmonology. Der Pneumologe 14:2, pages 89-96.
Crossref
Crossref